219 related articles for article (PubMed ID: 10937952)
1. Haemodynamic, neurohumoral and exercise effects of losartan vs. captopril in chronic heart failure: results of an ELITE trial substudy. Evaluation of Losartan in the Elderly.
Houghton AR; Harrison M; Cowley AJ
Eur J Heart Fail; 1999 Dec; 1(4):385-93. PubMed ID: 10937952
[TBL] [Abstract][Full Text] [Related]
2. Effects of losartan and captopril on left ventricular volumes in elderly patients with heart failure: results of the ELITE ventricular function substudy.
Konstam MA; Patten RD; Thomas I; Ramahi T; La Bresh K; Goldman S; Lewis W; Gradman A; Self KS; Bittner V; Rand W; Kinan D; Smith JJ; Ford T; Segal R; Udelson JE
Am Heart J; 2000 Jun; 139(6):1081-7. PubMed ID: 10827391
[TBL] [Abstract][Full Text] [Related]
3. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE).
Pitt B; Segal R; Martinez FA; Meurers G; Cowley AJ; Thomas I; Deedwania PC; Ney DE; Snavely DB; Chang PI
Lancet; 1997 Mar; 349(9054):747-52. PubMed ID: 9074572
[TBL] [Abstract][Full Text] [Related]
4. Randomised comparison of losartan vs. captopril on quality of life in elderly patients with symptomatic heart failure: the losartan heart failure ELITE quality of life substudy.
Cowley AJ; Wiens BL; Segal R; Rich MW; Santanello NC; Dasbach EJ; Pitt B;
Qual Life Res; 2000; 9(4):377-84. PubMed ID: 11131930
[TBL] [Abstract][Full Text] [Related]
5. Effects of two different enalapril dosages on clinical, haemodynamic and neurohumoral response of patients with severe congestive heart failure.
Pacher R; Stanek B; Globits S; Berger R; Hülsmann M; Wutte M; Frey B; Schuller M; Hartter E; Ogris E
Eur Heart J; 1996 Aug; 17(8):1223-32. PubMed ID: 8869864
[TBL] [Abstract][Full Text] [Related]
6. Effects of a new angiotensin-converting enzyme inhibitor, alacepril, on changes in neurohormonal factors and arterial baroreflex sensitivity in patients with congestive heart failure.
Kinugawa T; Kato M; Mori M; Endo A; Kato T; Hamada T; Noguchi N; Omodani H; Osaki S; Ogino K; Miyakoda H; Hisatome I; Shigemasa C
Eur J Clin Pharmacol; 1998 May; 54(3):209-14. PubMed ID: 9681661
[TBL] [Abstract][Full Text] [Related]
7. Acute effects of angiotensin-converting enzyme inhibition versus angiotensin II receptor blockade on cardiac sympathetic activity in patients with heart failure.
Azevedo ER; Mak S; Floras JS; Parker JD
Am J Physiol Regul Integr Comp Physiol; 2017 Oct; 313(4):R410-R417. PubMed ID: 28679681
[TBL] [Abstract][Full Text] [Related]
8. Combined treatment with losartan and an ACE inhibitor in mild to moderate heart failure: results of a double-blind, randomized, placebo-controlled trial.
Houghton AR; Harrison M; Cowley AJ; Hampton JR
Am Heart J; 2000 Nov; 140(5):e25. PubMed ID: 11054627
[TBL] [Abstract][Full Text] [Related]
9. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.
Pitt B; Poole-Wilson PA; Segal R; Martinez FA; Dickstein K; Camm AJ; Konstam MA; Riegger G; Klinger GH; Neaton J; Sharma D; Thiyagarajan B
Lancet; 2000 May; 355(9215):1582-7. PubMed ID: 10821361
[TBL] [Abstract][Full Text] [Related]
10. ADEPT: Addition of the AT1 receptor antagonist eprosartan to ACE inhibitor therapy in chronic heart failure trial: hemodynamic and neurohormonal effects.
Murdoch DR; McDonagh TA; Farmer R; Morton JJ; McMurray JJ; Dargie HJ
Am Heart J; 2001 May; 141(5):800-7. PubMed ID: 11320369
[TBL] [Abstract][Full Text] [Related]
11. Acute and long-term haemodynamic and neurohumoral response to nisoldipine vs captopril in patients with heart failure: a randomized double-blind study.
Schofer J; Hobuss M; Aschenberg W; Tews A
Eur Heart J; 1990 Aug; 11(8):712-21. PubMed ID: 1975780
[TBL] [Abstract][Full Text] [Related]
12. Effects of losartan versus captopril on mortality in patients with symptomatic heart failure: rationale, design, and baseline characteristics of patients in the Losartan Heart Failure Survival Study--ELITE II.
Pitt B; Poole-Wilson P; Segal R; Martinez FA; Dickstein K; Camm AJ; Konstam MA; Riegger G; Klinger GH; Neaton J; Sharma D; Thiyagarajan B
J Card Fail; 1999 Jun; 5(2):146-54. PubMed ID: 10404354
[TBL] [Abstract][Full Text] [Related]
13. Comparative effects of losartan and enalapril on exercise capacity and clinical status in patients with heart failure. The Losartan Pilot Exercise Study Investigators.
Lang RM; Elkayam U; Yellen LG; Krauss D; McKelvie RS; Vaughan DE; Ney DE; Makris L; Chang PI
J Am Coll Cardiol; 1997 Oct; 30(4):983-91. PubMed ID: 9316528
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
15. [The effect of bunazosin vs captopril on hemodynamic and neurohumoral parameters in patients with congestive heart failure].
Kawahara Y; Hasegawa K; Sawayama T; Inoue S; Nakamura T; Kakumae S; Tadaoka S; Nakao M; Nezuo S
Kokyu To Junkan; 1989 Dec; 37(12):1333-40. PubMed ID: 2575781
[TBL] [Abstract][Full Text] [Related]
16. Comparison of losartan and captopril on heart failure-related outcomes and symptoms from the losartan heart failure survival study (ELITE II).
Konstam MA; Neaton JD; Poole-Wilson PA; Pitt B; Segal R; Sharma D; Dasbach EJ; Carides GW; Dickstein K; Riegger G; Camm AJ; Martinez FA; Bradstreet DC; Ikeda LS; Santoro EP;
Am Heart J; 2005 Jul; 150(1):123-31. PubMed ID: 16084158
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the effects of losartan and enalapril on clinical status and exercise performance in patients with moderate or severe chronic heart failure.
Dickstein K; Chang P; Willenheimer R; Haunsø S; Remes J; Hall C; Kjekshus J
J Am Coll Cardiol; 1995 Aug; 26(2):438-45. PubMed ID: 7608448
[TBL] [Abstract][Full Text] [Related]
18. Effects of losartan and captopril on left ventricular systolic and diastolic function after acute myocardial infarction: results of the Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan (OPTIMAAL) echocardiographic substudy.
Møller JE; Dahlström U; Gøtzsche O; Lahiri A; Skagen K; Andersen GS; Egstrup K;
Am Heart J; 2004 Mar; 147(3):494-501. PubMed ID: 14999200
[TBL] [Abstract][Full Text] [Related]
19. Losartan: a review of its use, with special focus on elderly patients.
Simpson KL; McClellan KJ
Drugs Aging; 2000 Mar; 16(3):227-50. PubMed ID: 10803861
[TBL] [Abstract][Full Text] [Related]
20. Blockade of the renin-angiotensin system in heart failure in conscious dogs.
Murakami M; Suzuki H; Naitoh M; Matsumoto A; Kageyama Y; Tsujimoto G; Saruta T
J Hypertens; 1995 Dec; 13(12 Pt 1):1405-12. PubMed ID: 8866902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
